Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| Pfizer Inc. (NYSE: PFE) | Delayed: 29.72 -0.39 (1.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.11 | 52 Week High | $37.39 | |||
| Open | $30.00 | 52 Week Low | $28.25 | |||
| Day High | $30.09 | P/E | 18.01 | |||
| Day Low | $29.69 | EPS | $1.65 | |||
| Volume | 10,176,741 | |||||
